Literature DB >> 25242311

Case of a healthy infant born following antenatal enterovirus myocarditis and hydrops.

Aurore Bonnin1, Mikael Tassin1, Christelle Vauloup-Fellous2, Emmanuelle Letamendia3, Bertrand Stos4, Damien Bonnet5, Vincent Gajdos6, Mylène Mabille7, Alexandra Benachi8.   

Abstract

Fetal hydrops and myocarditis were diagnosed in a woman at 32 weeks of gestation (WG). Transplacental enterovirus infection was suspected because all other causes of myocarditis and hydrops were excluded, it was during an endemic period, and there was a setting of maternal infection (fever a few days before). We opted for in utero treatment because of the risk of resuscitating a neonate with myocarditis and hydrops. We administered dexamethasone 12mg twice for pulmonary maturation and presumed it would partially improve the myocarditis. Fetal arrhythmia was noted at 35 WG and we decided to deliver the infant as postnatal treatment of the heart disorder would be more effective. RT-PCR (ARGENE(®)) showed that the neonate's throat and anal tissues and cord blood sampled on the day of birth contained enterovirus ribonucleic acid and coxsackievirus B5, as did the mother's anal sample. Laboratory tests, heart MRI and probably brain MRI indicated neonatal enterovirus infection. Findings were normal at two-year follow-up.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antenatal; Enteroviruses; Healthy infant; Hydrops; Myocarditis

Mesh:

Substances:

Year:  2014        PMID: 25242311     DOI: 10.1016/j.jcv.2014.08.028

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  2 in total

1.  Adverse effects of maternal enterovirus infection on the pregnancy outcome: a prospective and retrospective pilot study.

Authors:  Z Khediri; C Vauloup-Fellous; A Benachi; J M Ayoubi; L Mandelbrot; O Picone
Journal:  Virol J       Date:  2018-04-16       Impact factor: 4.099

2.  Clinical characteristics of severe neonatal enterovirus infection: a systematic review.

Authors:  Meng Zhang; Haoran Wang; Jun Tang; Yang He; Tao Xiong; Wenxing Li; Yi Qu; Dezhi Mu
Journal:  BMC Pediatr       Date:  2021-03-15       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.